Page last updated: 2024-08-26

mafosfamide and prednisolone

mafosfamide has been researched along with prednisolone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broekema, GJ; Dirven, MW; Hählen, K; Heyenbrok, MW; Huismans, DR; Loonen, AH; Pieters, R; Veerman, AJ1
Hählen, K; Kaspers, GJ; Pieters, R; Van Wering, ER; Van Zantwijk, I; Veerman, AJ1
Bosanquet, AG; Bosanquet, MI1
Bahrami, SB; Beirne, E; Bertout, JA; Carleton, M; Casalini, JR; Chopra, R; Deckwerth, TL; Dey, J; Ditzler, SH; Filvaroff, EH; Frazier, JP; Girard, EJ; Grenley, MO; Hatton, BA; Kerwin, WS; Klinghoffer, RA; Meleo, KA; Moreno-Gonzalez, A; Morris, SM; Olson, JM; Pedro, KD; Press, OW; Strand, AD; Thirstrup, DJ; Tretyak, I; Veiseh, M; Watts, KL; You, S1

Other Studies

4 other study(ies) available for mafosfamide and prednisolone

ArticleYear
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
    Blood, 1990, Dec-01, Volume: 76, Issue:11

    Topics: Asparaginase; Cells, Cultured; Child; Coloring Agents; Culture Media; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Mechlorethamine; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thiazoles; Thioguanine; Vincristine

1990
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
    Leukemia research, 1995, Volume: 19, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Drug Interactions; Drug Resistance; Humans; In Vitro Techniques; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine

1995
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
    Leukemia, 2000, Volume: 14, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorambucil; Cladribine; Comorbidity; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pentostatin; Prednisolone; Prognosis; Staining and Labeling; Tumor Cells, Cultured; Vidarabine; Vincristine

2000
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.
    Science translational medicine, 2015, Apr-22, Volume: 7, Issue:284

    Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cyclophosphamide; Dogs; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lymphoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Neoplasms; Prednisolone; TOR Serine-Threonine Kinases; Vincristine

2015